Large majorities of Wisconsinites support the protests against racial injustice and police brutality that have swept across the state in the last month, a new poll from the Marquette University Law School found.
UW Health is part of a new clinical trial working to combat COVID-19 among patients.
When Fannie Lou Hamer spoke to a predominantly white audience at the University of Wisconsin-Madison in 1971, the civil rights icon spoke of the time when she was 13 and asked her mother a seemingly innocent question.
“How come we wasn’t born white?”
It was the question of a young teenager growing up in the heart of the South, when ruthless racism was the norm.
UW-Madison announced on Wednesday it was one of 32 sites for a clinical trial testing an existing drug called ruxolitinib as a way to prevent a COVID-19 complication where a patient’s immune system kicks into deadly overdrive. Hospitals in Milwaukee and Madison are also investigating convalescent plasma from recovered patients to treat those with active infections.
“Absent these kinds of conversations, the status quo wins,” said Patricia Devine, psychology professor and director of the Prejudice Lab at University of Wisconsin-Madison. “And the status quo is being revealed to us to be unacceptable in terms of costing people their lives only because of the color of their skin. That can’t stand.
But Jonathan Kenoyer, an archaeologist and Indus expert at the University of Wisconsin, Madison, remains skeptical that the chicken arose in Southeast Asia. “They need to get ancient DNA” to back up their claims, he says, because genomes of modern birds may provide limited clues to early events in chicken evolution.
Scholars are brimming with ideas to construct a more generous safety net on a permanent basis, bolstering everything from Medicaid to child care support. Timothy Smeeding, a professor of economics and public affairs at the University of Wisconsin, Madison, suggests that the federal government pick up the entire tab for Medicaid, which it now shares with the states.
It led to a PhD in the University of Wisconsin-Madison and a career with the pharmaceutical company Merck in the US – he still lives in Massachusetts.
Its founder and chief executive, Colin Zheng Huang, who earned his master’s from the University of Wisconsin-Madison and later worked at Google, is now China’s third-richest man, behind Jack Ma, the founder of Alibaba.
Noted: Before becoming an attorney and moving to the Harlem neighborhood in New York City, Adkins, 30, completed his undergraduate degree at the University of Wisconsin-Madison.
“It was weird having a best friend who was white and still feeling so isolated and uncomfortable by the whiteness on the campus,” he said. “I still enjoyed my time there very much, but I’m just talking about having to grapple with my double consciousness in a very real way.”
